Evidence map›Paper›PMID 34578551›Full record

ArticleNanomaterials (Basel, Switzerland)2021

Using Gold-Nanorod-Filled Mesoporous Silica Nanobeads for Enhanced Radiotherapy of Oral Squamous Carcinoma.

Mei-Hsiu Chen, Ming-Hong Chen, Chia-Ying Li, Fu-I Tung, San-Yuan Chen, Tse-Ying Liu

Abstract read
In one paragraph

Article in Nanomaterials (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Review
  2. Innovative nanoparticle strategies for treating oral cancers.Medical oncology (Northwood, London, England) · 2025
    Review
  3. Review
  4. Article
  5. Review
  6. Review
  7. Review
  8. Review
  9. Review
  10. Pharmaceutics · 2023
    Review
  11. Review
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Mei-Hsiu ChenDepartment of Internal Medicine, Far Eastern Memorial Hospital, New Taipei 220, Taiwan.
Ming-Hong ChenGraduate Institute of Nanomedicine and Medical Engineering, Taipei Medical University, Taipei 110, Taiwan.ORCID 0000-0001-6306-0818
Chia-Ying LiDepartment of Biomedical Engineering, National Yang Ming Chiao Tung University, Taipei 112, Taiwan.ORCID 0000-0002-1732-8980
Fu-I TungDepartment of Orthopaedic Surgery, Taipei City Hospital, Taipei 112, Taiwan.
San-Yuan ChenDepartment of Materials Science and Engineering, National Yang Ming Chiao Tung University, Hsinchu 300, Taiwan.ORCID 0000-0002-6500-2993
Tse-Ying LiuDepartment of Biomedical Engineering, National Yang Ming Chiao Tung University, Taipei 112, Taiwan.ORCID 0000-0002-1425-420X

Funding

Department of Health, Taipei City Government 10901-62-041Department of Health, Taipei City Government 11001-62-009Far Eastern Memorial Hospital, Taiwan FEMH-2021-C-018Ministry of Science and Technology, Taiwan MOST 107-2823-8-010-002Ministry of Science and Technology, Taiwan MOST 108-2314-B-010-035-MY3Ministry of Science and Technology, Taiwan MOST 109-2221-E-010-020-MY2
6 · The paper itself

Abstract

Radiotherapy (RT), in combination with surgery, is an essential treatment strategy for oral cancer. Although irradiation provides effective control over tumor growth, the surrounding normal tissues are almost inevitably affected. With further understanding of the molecular mechanisms involved in radiation response and recent advances in nanotechnology, using gold nanoparticles as a radiosensitizer provides the preferential sensitization of tumor cells to radiation and minimizes normal tissue damage. Herein, we developed gold nano-sesame-beads (GNSbs), a gold-nanorod-seeded mesoporous silica nanoparticle, as a novel radioenhancer to achieve radiotherapy with a higher therapeutic index. GNSbs in combination with 2 Gy irradiation effectively enhanced the cytotoxic activity CAL-27 cells. The well-designed structure of GNSbs showed preferential cellular uptake by CAL-27 cells at 24 h after incubation. Gold nanorods with high density modified on mesoporous silica nanoparticles resulted in significant reactive oxygen species (ROS) formation after irradiation exposure compared with irradiation alone. Furthermore, GNSbs and irradiation induced more prominent DNA double-strand breaks and G2/M phase arrest in CAL-27 than those in L929. In animal studies, radiotherapy using GNSbs as a radiosensitizer showed significant suppression of tumor growth in an orthotopic model of oral cancer. These results demonstrate that using GNSbs as a radiosensitizer could possess clinical potential for the treatment of oral squamous carcinoma.

Indexed as

gold nanoparticlesmesoporous silicaoral cancerradiosensitizerradiotherapy

Identifiers

PMID34578551
PMCPMC8472528

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.